Ar 29 Ebrill, ynghyd â gweddill y DU, gwnaethom weithredu Protocolau Prinder Difrifol (SSP) ar gyfer tri chynnyrch HRT sy’n brin eu cyflenwad – jel Oestrogel, eli Ovestin a thabledi Premique dos isel a ryddheir dan reolaeth. Mae’r Protocolau’n caniatáu i fferyllwyr cymunedol gyfyngu ar faint o’r cynhyrchion hyn sy’n cael eu darparu i ddim mwy na’r hyn sy’n cyfateb i dri mis o driniaeth.
On 29 April, together with the rest of the UK, we implemented Serious Shortage Protocols (SSPs), allowing community pharmacists to limit the quantity of three HRT products – Oestrogel gel, Ovestin cream, and Premique low-dose modified-release tablets – which are experiencing supply issues, to no more than the equivalent of three months’ treatment.